
Download PDF CAMBRIDGE, MA, May 15, 2008 – AVEO Pharmaceuticals, Inc. today announced that Tuan Ha-Ngoc, president and chief executive officer, is scheduled to present at the 2008 Citi Investment Research Global Health Care Conference on Thursday, May 22, 2008 at 11:00 a.m. (ET) at the Hilton New York in New York City. About AVEO
Download PDF CAMBRIDGE, MA, May 2, 2008 – AVEO Pharmaceuticals, Inc. today announced that Tuan Ha-Ngoc, president and chief executive officer, is scheduled to present at the Leerink Swann Solid Tumors Roundtable Conference on Friday, May 9, 2008 at 10:20 a.m. (ET) at the Grand Hyatt in New York City. In addition, Murray Robinson, Ph.D.,
Download PDF Proprietary Human Response Platform Data Reveal Distinct Biomarkers PotentiallyCritical to Determining Treatment Success SAN DIEGO, Calif and CAMBRIDGE, Mass, April 14, 2008 – AVEO Pharmaceuticals, Inc., a biotechnology company leveraging breakthrough discoveries in cancer biology to discover, develop and commercialize targeted oncology therapies, today announced that their novel oral triple VEGF receptor inhibitor
Download PDF Six Abstracts on AVEO’s Proprietary Human Response Platform Also to be PresentedCAMBRIDGE, Mass., April 8, 2008 — AVEO Pharmaceuticals, Inc., a biotechnology company leveraging breakthrough discoveries in cancer biology to discover, develop and commercialize targeted oncology therapies, today announced that it will present a total of six oral and poster presentations at the
Download PDF CAMBRIDGE, MA, March 20, 2008 – AVEO Pharmaceuticals, Inc. today announced that Elan Ezickson, chief business officer, is scheduled to present at the Future Leaders in the Biotech Industry Conference on Thursday, March 27, 2008 at 2:00 p.m. (ET) at the Millennium Broadway Hotel in New York City. About AVEO AVEO is a
Download PDF CAMBRIDGE, MA, March 12, 2008 – AVEO Pharmaceuticals, Inc. today announced that Tuan Ha-Ngoc, president and chief executive officer, is scheduled to present at the Cowen and Company 28th Annual Health Care Conference on Wednesday, March 19, 2008 at 4:00 p.m. (ET) at the Boston Marriott Copley Place. About AVEO AVEO is a
Download PDF CAMBRIDGE, MA, February 5, 2008 – AVEO Pharmaceuticals, Inc. today announced that Tuan Ha-Ngoc, president and chief executive officer, is scheduled to present at the 10th Annual BIO CEO & Investor Conference on Tuesday, February 12, 2008 at 1:15 p.m. (ET) at the Waldorf-Astoria in New York City. About AVEO AVEO is a
Download PDF CAMBRIDGE, MA, January 31, 2008 – AVEO Pharmaceuticals, Inc., a biotechnology company leveraging breakthrough discoveries in cancer biology to discover, develop and commercialize targeted oncology therapies, today announced that it has initiated a Phase 1b clinical trial for its lead product candidate, the novel triple VEGF receptor inhibitor AV-951, in combination with the
For media inquiries, please contact:
John F. Kouten, CEO
JFK Communications, Inc.
jfkouten@jfkhealth.com
Direct: 609-241-7352
The AVEO oncology management team comprises executives with years of oncology and pharmaceutical industry experience and expertise with a proven track record for success in bringing important new therapies to patients.